Liver transplant study for liver cancer patients
Part of Cancer, Digestive system, Heart & circulation clinical trials.
This study tests a special way to preserve donated livers before transplant to see if it reduces the chance of liver cancer coming back after surgery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have liver cancer that meets specific size and number criteria (Milan criteria).
- You are on the waiting list for a liver transplant.
- You are in good enough health to be up and taking care of yourself (ECOG 0-2).
- The donated liver comes from a donor after brain death (not after cardiac death).
- You are able to understand and sign a consent form.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies whether using an “ex vivo perfusion” process—keeping a donor liver alive outside the body before transplant—can improve outcomes for certain people who need a liver transplant but have limited options. It may help patients who are too high-risk for standard transplant timing or options, including some cancer-related liver disease cases.
This study tests a new way to preserve donated livers using a machine that keeps the organ cool and oxygenated before transplant. It may help improve how well the liver works after the surgery.
This study looks at two blood markers (AFP and PIVKA-II) to see if they can help predict outcomes for people getting a liver transplant for liver cancer. It aims to find better ways to guide care after transplant.
This study tests whether a special way of moving blood through the donor abdomen before surgery can improve liver (and other organ) transplant quality. It may help because doctors can check how well the liver seems to be working before it’s actually used.
This trial is testing whether liver transplantation is safe and effective for people with liver cancer that has spread into the bile ducts (tumor thrombus). It may help patients whose only treatment option is a transplant.
This study looks at liver tissue before transplantation to find ways to predict how well the transplant will work. It involves a special treatment called HOPE to help preserve the liver.
Hear when a new Hepatocellular Carcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.